Pathogenesis of human systemic lupus erythematosus: recent advances

被引:264
作者
Crispin, Jose C. [1 ]
Liossis, Stamatis-Nick C. [2 ]
Kis-Toth, Katalin [1 ]
Lieberman, Linda A. [1 ]
Kyttaris, Vasileios C. [1 ]
Juang, Yuang-Taung [1 ]
Tsokos, George C. [1 ]
机构
[1] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Dept Med,Div Rheumatol, Boston, MA 02115 USA
[2] Univ Patras, Sch Med, Patras Univ Hosp, Dept Med,Div Rheumatol, GR-26110 Patras, Greece
关键词
EPSTEIN-BARR-VIRUS; PLASMACYTOID DENDRITIC CELLS; SUPPRESSES IL-2 PRODUCTION; PROTEIN PHOSPHATASE 2A; INNATE IMMUNE-RESPONSE; T-CELLS; DISEASE-ACTIVITY; DNA METHYLATION; PRONE MICE; FUNCTIONAL VARIANTS;
D O I
10.1016/j.molmed.2009.12.005
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Systemic lupus erythematosus (SLE) is an autoimmune disease with manifestations derived from the involvement of multiple organs including the kidneys, joints, nervous system and hematopoietic organs. Immune system aberrations, as well as heritable, hormonal and environmental factors interplay in the expression of organ damage. Recent contributions from different fields have developed our understanding of SLE and reshaped current pathogenic models. Here, we review recent findings that deal with (i) genes associated with disease expression; (ii) immune cell molecular abnormalities that lead to autoimmune pathology; (iii) the role of hormones and sex chromosomes in the development of disease; and (iv) environmental and epigenetic factors thought to contribute to the expression of SLE. Finally, we highlight molecular defects intimately associated with the disease process of SLE that might represent ideal therapeutic targets and disease biomarkers.
引用
收藏
页码:47 / 57
页数:11
相关论文
共 141 条
[1]   STAT4 associates with systemic lupus erythematosus through two independent effects that correlate with gene expression and act additively with IRF5 to increase risk [J].
Abelson, A-K ;
Delgado-Vega, A. M. ;
Kozyrev, S. V. ;
Sanchez, E. ;
Velazquez-Cruz, R. ;
Eriksson, N. ;
Wojcik, J. ;
Reddy, M. V. P. Linga ;
Lima, G. ;
D'Alfonso, S. ;
Migliaresi, S. ;
Baca, V. ;
Orozco, L. ;
Witte, T. ;
Ortego-Centeno, N. ;
Abderrahim, H. ;
Pons-Estel, B. A. ;
Gutierrez, C. ;
Suarez, A. ;
Gonzalez-Escribano, M. F. ;
Martin, J. ;
Alarcon-Riquelme, M. E. .
ANNALS OF THE RHEUMATIC DISEASES, 2009, 68 (11) :1746-1753
[2]   LJP 394 for the prevention of renal flare in patients with systemic lupus erythematosus -: Results from a randomized, double-blind, placebo-controlled study [J].
Alarcón-Segovia, D ;
Tumlin, JA ;
Furie, RA ;
McKay, JD ;
Cardiel, MH ;
Strand, V ;
Bagin, RG ;
Linnik, MD ;
Hepburn, B .
ARTHRITIS AND RHEUMATISM, 2003, 48 (02) :442-454
[3]   Identification of new SLE-associated genes with a two-step Bayesian study design [J].
Armstrong, D. L. ;
Reiff, A. ;
Myones, B. L. ;
Quismorio, F. P., Jr. ;
Klein-Gitelman, M. ;
McCurdy, D. ;
Wagner-Weiner, L. ;
Silverman, E. ;
Ojwang, J. O. ;
Kaufman, K. M. ;
Kelly, J. A. ;
Merrill, J. T. ;
Harley, J. B. ;
Bae, S-C ;
Vyse, T. J. ;
Gilkeson, G. S. ;
Gaffney, P. M. ;
Moser, K. L. ;
Putterman, C. ;
Edberg, J. C. ;
Brown, E. E. ;
Ziegler, J. ;
Langefeld, C. D. ;
Zidovetzki, R. ;
Jacob, C. O. .
GENES AND IMMUNITY, 2009, 10 (05) :446-456
[4]   Parvovirus B19 infection and systemic lupus erythematosus: Activation of an aberrant pathway? [J].
Aslanidis, Spyros ;
Pyrpasopoulou, Athina ;
Kontotasios, Kostas ;
Doumas, Stella ;
Zamboulis, Chryssanthos .
EUROPEAN JOURNAL OF INTERNAL MEDICINE, 2008, 19 (05) :314-318
[5]   Pathogenesis of kidney disease in systemic lupus erythematosus [J].
Bagavant, Harini ;
Fu, Shu Man .
CURRENT OPINION IN RHEUMATOLOGY, 2009, 21 (05) :489-494
[6]   Transcript levels of DNA methyltransferases DNMT1, DNMT3A and DNMT3B in CD4+ T cells from patients with systemic lupus erythematosus [J].
Balada, Eva ;
Ordi-Ros, Josep ;
Serrano-Acedo, Silvia ;
Martinez-Lostao, Luis ;
Rosa-Leyva, Maria ;
Vilardell-Tarres, Miquel .
IMMUNOLOGY, 2008, 124 (03) :339-347
[7]   The epigenetic face of systemic lupus erythematosus [J].
Ballestar, E ;
Esteller, M ;
Richardson, BC .
JOURNAL OF IMMUNOLOGY, 2006, 176 (12) :7143-7147
[8]   Induction of dendritic cell differentiation by IFN-α in systemic lupus erythematosus [J].
Blanco, P ;
Palucka, AK ;
Gill, M ;
Pascual, V ;
Banchereau, J .
SCIENCE, 2001, 294 (5546) :1540-1543
[9]   Decreased transcription of the human FCGR2B gene mediated by the-343 G/C promoter polymorphism and association with systemic lupus erythematosus [J].
Blank, MC ;
Stefanescu, RN ;
Masuda, E ;
Marti, F ;
King, PD ;
Redecha, PB ;
Wurzburger, RJ ;
Peterson, MGE ;
Tanaka, S ;
Pricop, L .
HUMAN GENETICS, 2005, 117 (2-3) :220-227
[10]   Cr2, a candidate gene in the murine Sle1c lupus susceptibility locus, encodes a dysfunctional protein [J].
Boackle, SA ;
Holers, VM ;
Chen, XJ ;
Szakonyi, G ;
Karp, DR ;
Wakeland, EK ;
Morel, L .
IMMUNITY, 2001, 15 (05) :775-785